Our 5th annual CBRNe Summit Europe conference and exhibition will be heading back to Rome, Italy where we will be evaluating the developments in CBRNe capabilities across Europe. The threat of CBRNe attacks across Europe is continuing to increase year on year.
Download Conference Agenda |... Read the full story
The evolving threat of chemical, biological, radiological, nuclear, and high-yield weapons (CBRNE) is a reality at home and abroad. Countering these threats requires rapid research and solution development to ensure the safety of our war fighters and of American citizens. Alion is pleased to... Read the full story
Engility Holdings, Inc. (NYSE: EGL) secured a position on the Joint Program Executive Office for Chemical and Biological Defense Joint Enterprise Research Development Acquisition and Procurement Omnibus contract. The $8 billion multi-award Indefinite Delivery Indefinite Quantity vehicle allows the... Read the full story